OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
11
Results
Show all
Save search
Copy query
Show results for
Unknown
(11)
Publication Date
Release Date
2024
(3)
2021
(2)
2025
(1)
2023
(1)
2020
(1)
2019
(1)
2018
(1)
2017
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and ER stress as independent binary adaptive responses.
Not available
S-EPMC6764980
|
biostudies-literature
Cite
Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance).
Not available
S-EPMC5493050
|
biostudies-literature
Cite
Effects of meglumine antimoniate and allopurinol treatment on the fecal microbiome profile in dogs with leishmaniosis.
Not available
S-EPMC12288312
|
biostudies-literature
Cite
Improved biosensing of Legionella by integrating filtration and immunomagnetic separation of the bacteria retained in filters.
Not available
S-EPMC10774190
|
biostudies-literature
Cite
A longitudinal prospective study of active tuberculosis in a Western Europe setting: insights and findings.
Not available
S-EPMC10954962
|
biostudies-literature
Cite
Obstetrical providers' preferred mode of delivery and attitude towards non-medically indicated caesarean sections: a cross-sectional study.
Not available
S-EPMC6041183
|
biostudies-literature
Cite
Efficacy and Safety of Sarilumab in patients with COVID19 Pneumonia: A Randomized, Phase III Clinical Trial (SARTRE Study).
Not available
S-EPMC8520759
|
biostudies-literature
Cite
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Not available
S-EPMC10794000
|
biostudies-literature
Cite
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study.
Not available
S-EPMC8231091
|
biostudies-literature
Cite
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Not available
S-EPMC10867612
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets